Peripheral Artery Occlusive Disease Among Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-Control Study | Zendy

Thanawat Rattanathammethee | Zendy; Adisak Tantiworawit | Zendy; Ekarat Rattarittamrong | Zendy; Chatree ChaiAdisaksopha | Zendy; Sasinee Hantrakool | Zendy; Arintaya Phrommintikul | Zendy; Wanwarang Wongcharoen | Zendy; Siriluck Gunaparn | Zendy; Lalita Norasetthada | Zendy

Open Access

Peripheral Artery Occlusive Disease Among Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-Control Study

Author(s) -

Thanawat Rattanathammethee,

Adisak Tantiworawit,

Ekarat Rattarittamrong,

Chatree ChaiAdisaksopha,

Sasinee Hantrakool,

Arintaya Phrommintikul,

Wanwarang Wongcharoen,

Siriluck Gunaparn,

Lalita Norasetthada

Publication year - 2017

Publication title -

clinical medicine insights cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 21

ISSN - 1179-5468

DOI - 10.1177/1179546817747258

Subject(s) - medicine , nilotinib , myeloid leukemia , odds ratio , dasatinib , diabetes mellitus , imatinib , case control study , imatinib mesylate , cardiology , gastroenterology , endocrinology

Peripheral artery occlusive disease was higher among patients with CML than the control, especially in patients who had diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research